About HandyLab
HandyLab is a Healthcare company based in Ann Arbor (United States) founded in 1999, and was acquired by Becton Dickinson in October 2009. Molecular diagnostic assays and automation platforms are developed. HandyLab has raised $30.7 million across 4 funding rounds from investors including Pfizer, HP and BD. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Bacterial. Its legal entity is HANDYLAB, INC. Its competitors include Karius, Day Zero Diagnostics and OpGen; 3 of its 3 listed competitors have raised funding.
Company details
HandyLab was founded in 1999 in Ann Arbor, United States, and operates within the biotechnology sector focused on molecular diagnostics. Assays and automation platforms are developed, including the HandyLab Jaguar system, which integrates sample preparation, nucleic acid extraction, and real-time PCR amplification and detection. This bench-top setup supports on-demand and batch processing for clinical workflows, with results generated in real time.
- Headquarters Ann Arbor, United States
- Stage Acquired
- SectorsHealthcare
- Website handylab.com
- Acquired by Becton Dickinson (Oct 2009)
- Legal Name Handylab, Inc
- Total Equity Funding$30.7M (USD)
in 4 rounds
- Latest Funding Round$19.2M (USD), Series D
Aug 2008
- InvestorsPfizer
& 8 more
- Acquired byBecton Dickinson
(Oct 2009)
Funding Insights of HandyLab
HandyLab has successfully raised a total of $30.7M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $19.2 million completed in August 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30.7M
- Total Rounds 4
- Last Round Series D — $19.2M
- Investors Count 8
All 4 funding rounds of HandyLab with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2008 | $19.2M | Series D | – | Dow Chemical Company, Ann Lurie | |
| Jan 2006 | $6M | Series C | – | – | |
| Jun 2002 | $5.5M | Series B | – | – | |
| Jun 2000 | Series A | – | – |
9 investors in total: 9 institutional.
Investors in HandyLab
HandyLab has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Pfizer, HP and BD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage US tech and life science companies are invested in. | edfvc.com | Ann Arbor, United States | ||
Healthcare venture capital investments are made by Arboretum Ventures. | arboretumvc.com | Ann Arbor, United States | ||
A platform dedicated to partnership marketing insights. | sbvpartners.com | |||
| zli.umich.edu/wolverine-venture-fund | ||||
Dow Inc. is engaged in materials science and chemical manufacturing. | 1897 | dow.com | Saginaw, United States | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | pfizer.com | New York, United States | |
It serves as a private foundation focused on children welfare. | 1986 | annlurie.com | Chicago, United States | |
Hardware, software, and IT services are provided globally to businesses. | 1939 | hp.com | Palo Alto, United States | |
BD is recognized for providing innovative medical technology solutions. | 1897 | bd.com | Franklin Lakes, United States |
Investor details for HandyLab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of HandyLab
4 dated milestones of HandyLab across 10 years, from founding to its latest funding, stage changes and deals.
- Founded HandyLab is founded.
- Funding First funding round.
- Funding Latest funding round, Series D, of $19.2M.
- Exit Acquired by Becton Dickinson.
Competitors of HandyLab
HandyLab has 3 listed competitors in our database, 3 of them funded. They include Karius, Day Zero Diagnostics and OpGen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. | |
| opgen.com | 2002 | Rockville, United States | $77.51M | 100 | Developer of diagnostics and bioinformatics platforms for providers |
Detailed competitors of HandyLab
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as HandyLab (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Handylab
Complete news archive for HandyLab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HandyLab
HandyLab was founded in 1999 and raised its 1st funding round 1 year after it was founded.
HandyLab is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
HandyLab is a funded company, having raised a total of $30.7M across 4 funding rounds to date.
HandyLab was founded in 1999 in Ann Arbor, United States, and operates within the biotechnology sector focused on molecular diagnostics. Assays and automation platforms are developed, including the HandyLab Jaguar system, which integrates sample preparation, nucleic acid extraction, and real-time PCR amplification and detection. This bench-top setup supports on-demand and batch processing for clinical workflows, with results generated in real time.
HandyLab's top competitors include Day Zero Diagnostics, Karius and OpGen.
HandyLab has 9 investors. Key investors include Pfizer, HP, BD, Dow, and EDF Ventures.
HandyLab operates through Handylab, Inc.
Yes. HandyLab was acquired by Becton Dickinson in October 2009.